Aquestive Therapeutics, Inc.
AQST
$2.87
$0.020.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.06M | -11.51M | -2.75M | -12.83M | -8.11M |
| Total Depreciation and Amortization | 170.00K | 159.00K | 205.00K | 207.00K | 494.00K |
| Total Amortization of Deferred Charges | 2.70M | 2.67M | 2.67M | 2.67M | 1.80M |
| Total Other Non-Cash Items | 2.41M | 1.63M | 1.23M | 1.61M | 1.98M |
| Change in Net Operating Assets | 5.28M | -4.83M | -8.36M | -2.05M | -1.10M |
| Cash from Operations | -6.49M | -11.88M | -7.01M | -10.38M | -4.94M |
| Capital Expenditure | -15.00K | -80.00K | -35.00K | -29.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15.00K | -80.00K | -35.00K | -29.00K | -16.00K |
| Total Debt Issued | -- | -- | -- | -- | 31.14M |
| Total Debt Repaid | -5.00K | -8.00K | -5.00K | -5.00K | -38.98M |
| Issuance of Common Stock | 168.00K | 193.00K | 1.72M | 82.64M | 3.61M |
| Repurchase of Common Stock | -1.00K | -202.00K | -5.00K | -893.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.00K | -- | -- | -- | 8.14M |
| Cash from Financing | 157.00K | -17.00K | 1.71M | 81.74M | 3.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.35M | -11.98M | -5.33M | 71.33M | -1.05M |